Carcinoma, Non-Small-Cell Lung
"Carcinoma, Non-Small-Cell Lung" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
Descriptor ID |
D002289
|
MeSH Number(s) |
C04.588.894.797.520.109.220.249 C08.381.540.140.500 C08.785.520.100.220.500
|
Concept/Terms |
Carcinoma, Non-Small-Cell Lung- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Non Small Cell Lung
- Carcinomas, Non-Small-Cell Lung
- Lung Carcinoma, Non-Small-Cell
- Lung Carcinomas, Non-Small-Cell
- Non-Small-Cell Lung Carcinomas
- Nonsmall Cell Lung Cancer
- Non-Small-Cell Lung Carcinoma
- Non Small Cell Lung Carcinoma
- Carcinoma, Non-Small Cell Lung
- Non-Small Cell Lung Cancer
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Non-Small-Cell Lung".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Non-Small-Cell Lung".
This graph shows the total number of publications written about "Carcinoma, Non-Small-Cell Lung" by people in this website by year, and whether "Carcinoma, Non-Small-Cell Lung" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 11 | 2 | 13 |
1995 | 15 | 1 | 16 |
1996 | 11 | 4 | 15 |
1997 | 13 | 6 | 19 |
1998 | 14 | 3 | 17 |
1999 | 18 | 6 | 24 |
2000 | 24 | 5 | 29 |
2001 | 27 | 7 | 34 |
2002 | 32 | 5 | 37 |
2003 | 41 | 6 | 47 |
2004 | 53 | 5 | 58 |
2005 | 51 | 8 | 59 |
2006 | 54 | 11 | 65 |
2007 | 60 | 8 | 68 |
2008 | 72 | 8 | 80 |
2009 | 69 | 5 | 74 |
2010 | 69 | 11 | 80 |
2011 | 87 | 7 | 94 |
2012 | 83 | 12 | 95 |
2013 | 93 | 8 | 101 |
2014 | 88 | 5 | 93 |
2015 | 85 | 10 | 95 |
2016 | 74 | 7 | 81 |
2017 | 75 | 8 | 83 |
2018 | 91 | 11 | 102 |
2019 | 87 | 7 | 94 |
2020 | 115 | 8 | 123 |
2021 | 106 | 5 | 111 |
2022 | 108 | 2 | 110 |
2023 | 120 | 2 | 122 |
2024 | 57 | 10 | 67 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Non-Small-Cell Lung" by people in Profiles.
-
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung Cancer. Cancer Discov. 2024 Nov 01; 14(11):2183-2208.
-
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. J Immunother Cancer. 2024 Oct 23; 12(10).
-
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer. J Immunother Cancer. 2024 Oct 20; 12(10).
-
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024 Nov; 635(8038):462-471.
-
Can We Offset Local Recurrence in Locally Advanced Non-Small Cell Lung Cancer? The Merry-Go-Round of Radiation Dose Escalation and Stubborn Outcomes. J Clin Oncol. 2024 Nov 20; 42(33):3895-3900.
-
Non-small-cell lung cancer. Nat Rev Dis Primers. 2024 Sep 26; 10(1):71.
-
Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study. J Geriatr Oncol. 2024 Nov; 15(8):102071.
-
Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm. Support Care Cancer. 2024 Sep 16; 32(10):661.
-
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer. Cancer Cell. 2024 Sep 09; 42(9):1598-1613.e4.
-
Calibrating Observational Health Record Data Against a Randomized Trial. JAMA Netw Open. 2024 Sep 03; 7(9):e2436535.